View drug registration information details.


ItemsRegistration information
ID2871
No2871
Brand NameRESPICARE 4 MG
IngredientsMONTELUKAST SODIUM EQ.TO MONTELUKAST 4 MG
Dosage FormGRANULES
Primary PackagingSACHET
Storage
Shelf Life2 YEARS
Pack Size14 SACHETS/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsPROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA INCLUDING: THE PREVENTION OF DAY TIME AND NIGHT TIME SYMPTOMS, THE PREVENTION OF EXERCISED-INDUCED BRONCHOCONSTRICTION, ALSO RELIEF OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE OR OLDER
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionWHITE COLOR GRANULES
Note
License OwnerVIMPEX (LAO) CO.,LTD
ManufacturerGENIX PHARMA(PRIVATE) LTD.
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 I 4374/18
FDD Registration Date28-Mar-2025
Expiry Date27-Mar-2030

Back to drug list